Skip to content
AnalystLens

L3HARRIS TECHNOLOGIES, INC. /DE/ 8-K Report, Corporate Update (Nov 27, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed November 27, 2024
Period End
November 26, 2024
Security
LHX
In the record · 2016–202610-K1110-Q328-K177

LHX filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 177 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · May ’17May ’17
  2. Deal closed8-K · Jul ’19Jul ’19
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed November 27, 2024. Cited figures are marked; the original filing is the authoritative source.

L3Harris Technologies, Inc. (LHX) announced on November 26, 2024, that its CEO, Christopher E.

Kubasik, has established a pre-arranged stock option exercise and sale plan under Rule 10b5-1. This plan allows for the exercise of 112,138 vested stock options granted in February 2017 and the subsequent sale of the issued shares. The sales are scheduled to commence in March 2025 and conclude by March 25, 2025, contingent upon specific price thresholds.

This action, taken during an open trading window and without executive discretion over individual sales, aims to diversify Mr. Kubasik's holdings and ensure compliance with company stock ownership guidelines. The transactions will be publicly disclosed through SEC filings, providing transparency to investors. The company has stated it will not routinely report on similar plans established by other executives or directors.

Key Highlights

  1. CEO Christopher E. Kubasik has established a Rule 10b5-1 trading plan for stock options.
  2. The plan involves the exercise of 112,138 vested stock options granted in February 2017.
  3. Shares acquired through option exercise will be sold starting March 2025, concluding by March 25, 2025.
  4. Sales are subject to predetermined minimum price thresholds.
  5. The plan was adopted during an open trading window and executed without executive discretion over individual sales.
  6. Transactions will be disclosed via Form 4 and Form 144 filings.
  7. The company will not provide routine updates on other executive/director 10b5-1 plans.

Frequently Asked Questions

  1. What is a Rule 10b5-1 trading plan?

    A Rule 10b5-1 trading plan is a written document that pre-arranges the purchase or sale of securities by an insider (like a CEO) at a time when they do not possess material non-public information. This plan allows executives to buy or sell company stock at a predetermined time or based on predetermined criteria, providing an affirmative defense against insider trading allegations.

  2. Why is the CEO exercising stock options and selling shares?

    The CEO, Christopher E. Kubasik, is exercising vested stock options and selling shares as part of a pre-arranged plan. This is often done to diversify personal holdings, meet financial planning needs, or comply with company stock ownership guidelines, as indicated in this filing. The plan's structure under Rule 10b5-1 ensures these transactions are compliant with securities regulations.

  3. When will these stock sales take place and how will investors be informed?

    The sales are scheduled to begin in March 2025 and will conclude no later than March 25, 2025, subject to minimum price thresholds. All transactions under this plan will be publicly disclosed by L3Harris Technologies through filings of Form 4 (Changes in Beneficial Ownership) and potentially Form 144 (Securities to be Sold) with the SEC.

  4. Does this plan indicate any negative outlook for L3Harris Technologies?

    Generally, a Rule 10b5-1 plan itself does not indicate a negative outlook. It's a pre-planned, compliant method for executives to manage their stock holdings. The filing explicitly states the plan was established during an open trading window and that the CEO's ownership interest exceeds company guidelines, suggesting it's a proactive financial management strategy rather than a reaction to company performance.